No. of camps held
|
27
|
19
|
2
|
Mean no. of camp attendees$ (range)
|
12.9 (01 – 50)
|
11.8 (02 – 30)
|
29.5 (24 – 35)
|
% (No.) male
|
48% (168/349)
|
52.9% (119/225)
|
56% (33/59)
|
Mean (SD) age in years
|
27.4 (19.1)
|
33.1 (18.5)
|
33.8 (20.3)
|
Detection of VL
| | | |
- with splenomegaly
|
52% (183/349)
|
85.8% (193/225)
|
5% (3/59)
|
- rK39 test done
|
100% (183/183)
|
100% (193/193)
|
100% (3/3)
|
- rK39 positive
|
22% (40/183)
|
2.6% (5/193)
|
100% (3/3)
|
- referred for treatment
|
100% (40/40)
|
100% (5/5)
|
100% (3/3)
|
- completed treatment
|
33% (13/40)
|
100% (5/5)
|
100% (3/3)
|
- No. of new VL cases detected
|
40
|
5
|
3
|
- No. of new VL cases detected per camp
|
1.5
|
0.3
|
1.5
|
Detection of PKDL
| | | |
- with suspected skin lesions
|
5% (17/349)
|
2.2% (5/225)
|
0% (0/59)
|
- rK39 test done
|
100% (17/17)
|
100% (5/5)
|
--
|
- rK39 test positive
|
82% (14/17)
|
20% (1/5)
|
--
|
- referred for treatment
|
100% (14/14)
|
100% (1/1)
|
--
|
- completed treatment
|
0% (0/14)
|
100% (1/1)
|
--
|
- No. of new PKDL cases detected
|
14
|
1
|
0
|
- No. of new PKDL cases detected per camp
|
0.5
|
.05
|
0
|
No. of new cases (VL + PKDL) detected
|
54
|
6
|
3
|
No. of new cases detected per camp
|
2.0
|
0.32
|
1.5
|